Drug Patents owned by Mallinckrodt Inc

1. Drug name - XARTEMIS XR

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7976870 MALLINCKRODT INC Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract Jun, 2027

(4 years from now)

US8668929 MALLINCKRODT INC Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic Mar, 2029

(6 years from now)

US8394408 MALLINCKRODT INC Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic Mar, 2029

(6 years from now)

US8372432 MALLINCKRODT INC Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic Mar, 2029

(6 years from now)

US8377453 MALLINCKRODT INC Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic Nov, 2029

(7 years from now)

US8597681 MALLINCKRODT INC Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans Dec, 2030

(8 years from now)

US8980319 MALLINCKRODT INC Methods of producing stabilized solid dosage pharmaceutical compositions containing morphinans Dec, 2030

(8 years from now)

US8658631 MALLINCKRODT INC Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia May, 2032

(9 years from now)

US8741885 MALLINCKRODT INC Gastric retentive extended release pharmaceutical compositions May, 2032

(9 years from now)

US9468636 MALLINCKRODT INC Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia May, 2032

(9 years from now)

US8992975 MALLINCKRODT INC Combination composition comprising oxycodone and acetaminophen for rapid onset and extended duration of analgesia May, 2032

(9 years from now)

US9050335 MALLINCKRODT INC Pharmaceutical compositions for extended release of oxycodone and acetaminophen resulting in a quick onset and prolonged period of analgesia May, 2032

(9 years from now)

Drugs and Companies using ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE ingredient

Treatment: Method of treating patients with gastric retentive dosage form; Management of acute pain in patients requiring opioid analgesia

Dosage: TABLET, EXTENDED RELEASE;ORAL

More Information on Dosage
Strength Dosage Availability
325MG;7.5MG TABLET, EXTENDED RELEASE;ORAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.